Non-life post-pandemic strategy
Contenido multimedia no disponible por derechos de autor o por acceso restringido. Contacte con la institución para más información.
| Tag | 1 | 2 | Value |
|---|---|---|---|
| LDR | 00000cab a2200000 4500 | ||
| 001 | MAP20211003745 | ||
| 003 | MAP | ||
| 005 | 20210205144457.0 | ||
| 008 | 210205e20210101sgp|||p |0|||b|eng d | ||
| 040 | $aMAP$bspa$dMAP | ||
| 084 | $a32 | ||
| 100 | 1 | $0MAPA20170000556$aKhanna, Anoop | |
| 245 | 1 | 0 | $aNon-life post-pandemic strategy$cAnoop Khanna |
| 520 | $aDuring the pandemic, the focus of the Indian non-life industry has been entirely on health insurance but there is much more at stake. Asia Insurance Review spoke with three CEOs of non-life insurance companies to get their views on how important areas like pricing, profitability, product standardisation and business interruption will be viewed in 2021. | ||
| 650 | 4 | $0MAPA20080573935$aSeguros no vida | |
| 650 | 4 | $0MAPA20080590567$aEmpresas de seguros | |
| 650 | 4 | $0MAPA20080611880$aPerspectivas del seguro | |
| 650 | 4 | $0MAPA20080662257$aInterrupción de negocio | |
| 651 | 1 | $0MAPA20080663636$aIndia | |
| 773 | 0 | $wMAP20090003767$tAsia insurance review$dSingapore : Ins Communications Pte Ltd., 2009-$x0218-2696$g01/01/2021 Número 1 - Enero 2021 , p. 30-31 |